Document is current

Article History

First Online: 10 December 2020

Declarations

:

: No sources of funding were used to support the execution and writing of this research.

: JG has received speaker honoraria and consulting fees from Amgen, Biogen, Novartis, Sanofi, Mylan, and Samsung Bioepis. JEF has received unrestricted research grants or acted as a speaker for Abbvie, Ache, Amgen, BIAL, Biogen, BMS, Janssen, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi, and UCBF. FM has served as a speaker and received honoraria from Merck Sharp & Dohme, Abbvie, Vifor, Falk, Laboratórios Vitória, Ferring, Hospira, and Biogen. SD has served as a speaker, a consultant, and an advisory board member for Schering-Plough, Abbott Laboratories, Merck & Co, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, Alphawasserman, Genentech, Grunenthal, Pfizer, Astra Zeneca, Novo Nordisk, Cosmo Pharmaceuticals, Vifor, and Johnson and Johnson. RB, CA, NA, and JL have no conflicts of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: All data generated or analysed during this study are included in this published article and its supplementary information files.

: Not applicable.

: Conception and design of the study: RB, SD, JG. Acquisition of data: RB, CA. Interpretation and analysis of data: RB, CA, NA, JL, JG. Drafting the article or revising it critically for important intellectual content the article: all authors. Final approval of the version to be published: all authors.